These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22242803)

  • 1. Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
    Ceriello A; Cremasco F; Romoli E; Rossi A; Gentilella R
    Expert Opin Pharmacother; 2012 Feb; 13(2):255-81. PubMed ID: 22242803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Insulin Lispro Protamine Suspension in Pregnancy.
    Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
    Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes.
    Hompesch M; Ocheltree SM; Wondmagegnehu ET; Morrow LA; Kollmeier AP; Campaigne BN; Jacober SJ
    Curr Med Res Opin; 2009 Nov; 25(11):2679-87. PubMed ID: 19761358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trials.
    Esposito K; Chiodini P; Capuano A; Petrizzo M; Improta MR; Giugliano D
    Diabetes Care; 2012 Dec; 35(12):2698-705. PubMed ID: 23173139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
    Dalfrà MG; Soldato A; Moghetti P; Lombardi S; Vinci C; De Cata AP; Romanelli T; Bonomo M; Sciacca L; Tata F; Ragazzi E; Filippi A; Burlina S; Lapolla A
    J Matern Fetal Neonatal Med; 2016; 29(7):1061-5. PubMed ID: 25817082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
    Kaiserman K; Jung H; Benabbad I; Karges B; Polak M; Rosilio M
    Pediatr Diabetes; 2017 Mar; 18(2):81-94. PubMed ID: 27390032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
    Ocheltree SM; Hompesch M; Wondmagegnehu ET; Morrow L; Win K; Jacober SJ
    Eur J Endocrinol; 2010 Aug; 163(2):217-23. PubMed ID: 20508081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
    Andersen G; Meiffren G; Lamers D; DeVries JH; Ranson A; Seroussi C; Alluis B; Gaudier M; Soula O; Heise T
    Diabetes Obes Metab; 2018 Nov; 20(11):2627-2632. PubMed ID: 29923294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR342434 - an insulin biosimilar for the treatment of type II diabetes.
    Hu J; Wang M; Zhao Y
    Expert Opin Biol Ther; 2018 Nov; 18(11):1107-1112. PubMed ID: 30295083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insulin types in type 1 diabetes mellitus].
    Mesa J
    Med Clin (Barc); 2015 Jul; 145(2):70-5. PubMed ID: 25200067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin analogs in the treatment of type II diabetes and future perspectives.
    Sebastian SA; Co EL; Mehendale M; Hameed M
    Dis Mon; 2023 Mar; 69(3):101417. PubMed ID: 35487767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes.
    Giugliano D; Esposito K
    Ther Adv Endocrinol Metab; 2012 Jun; 3(3):99-108. PubMed ID: 23148201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.